A Five-Genes-Based Prognostic Signature for Cervical Cancer Overall Survival Prediction

Table 2

Association between ITM2A expression and the clinicopathological parameters of cervical cancer patients.

Clinicopathological parameters		Low expression	High expression	value
Age	<50 years	91	89	0.708
	>50 years	59	63
HPV status	Negative	6	3	0.430
	Positive	80	89
Histology	Adenocarcinoma	20	11	0.016
	Adenosquamous	3	0
	Squamous	63	81
Stage	I-II	63	78	0.138
	III-IV	20	14
Lymph node metastasis	Positive	15	18	0.572
	Negative	35	53

.